A recent study by Dr. Jordan Verplank, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the ...
The Grammy-winning musician went public about living — and performing — with a neurological condition called ...
SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder that’s both progressive and incurable. But now, nerve specialists ...
Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions.
and an estimated one million individuals with an inherited degenerative nerve condition called Charcot–Marie–Tooth disease type 2 (CMT2). Peripheral neuropathy can cause severe disability and ...
Alan Jackson's next farewell tour concert is on Saturday, Nov. 16, 2024, in Salt Lake City, Utah. In this file photo, he ...
Sara McCready launched Gnome and Away Travel in February with her husband Kevin. Becoming a Hays Travel Explorer franchisee ...
The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor in the Department of Human Genetics at the University of Utah. These grants ...
Mitochondria In Motion Inc. has identified new N-(trans-4-hydroxycyclohexyl)-6-phenylhexanamide derivatives acting as mitofusin activators and reported to be useful for the treatment of Alzheimer’s, ...
The research into the function of HDAC6 has also led to opportunities to use CKD-510 in other contexts, including the application to neurodegenerative diseases such as Charcot-Marie-Tooth disease ...
The next concert in Alan Jackson's farewell tour is on Saturday, Oct. 26, 2024, in Kansas City, Missouri. In this file photo, ...